Nephritis: Clinical Trials

6 trials for Nephritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 terminated. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Terminated 6

Follow Nephritis: new trials by email Literature Review of Nephritis trials Research Report on Nephritis

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fixed-dose Versus Concentration-controlled Mycophenolate Mofetil for the Treatment of Active Lupus Nephritis
Mycophenolate Mofetil - Lupus Nephritis
Phase 4TerminatedChulalongkorn University22019-08-202021-02-01
ACTHar in the Treatment of Lupus Nephritis
CellCept, ACTHar gel - Lupus Nephritis
Phase 4TerminatedColumbia University82014-10-012025-03-07
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
tacrolimus - Lupus Nephritis
Phase 4TerminatedAstellas Pharma Korea, Inc.372011-04-192024-10-31
Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment
ATG-F, Simulect - Glomerulonephritis, IgAN
Phase 4TerminatedCentre Hospitalier Universitaire de Saint Etienne1172011-01-082021-01-20
Aldosterone Breakthrough During Diovan, Tekturna, and Combination Therapy in Patients With Proteinuric Kidney Disease
Aliskiren, Valsartan - Proteinuric Kidney Disease, Diabetic Nephropathy
Phase 4TerminatedColumbia University462009-09-012014-05-15
Safety and Efficacy Study of the Treatment of Kidney Infections With Short Course Levofloxacin
Levofloxacin - Acute Uncomplicated Pyelonephritis
Phase 4TerminatedUniversity of Manitoba302004-09-012005-10-14

Narrower conditions

Lupus Nephritis (3)  ·  Diabetic Nephropathies (1)  ·  Glomerulonephritis (1)  ·  Glomerulonephritis, IGA (1)  ·  Glomerulonephritis, Membranous (1)  ·  Glomerulosclerosis, Focal Segmental (1)  ·  Proteinuria (1)  ·  Pyelonephritis (1)

Broader conditions

Female Urogenital Diseases (6)  ·  Female Urogenital Diseases and Pregnancy Complications (6)  ·  Kidney Diseases (6)  ·  Male Urogenital Diseases (6)  ·  Urogenital Diseases (6)  ·  Urologic Diseases (6)  ·  Autoimmune Diseases (4)  ·  Glomerulonephritis (4)  ·  Immune System Diseases (4)  ·  Connective Tissue Diseases (3)  ·  Lupus Erythematosus, Systemic (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Diabetes Complications (1)  ·  Diabetes Mellitus (1)

Interventions

Mycophenolic Acid (2)  ·  Adrenocorticotropic Hormone (1)  ·  Basiliximab (1)  ·  Levofloxacin (1)  ·  Tacrolimus (1)  ·  Valsartan (1)  ·  aliskiren (1)

Sponsors

Columbia University (2)  ·  Astellas Pharma Korea, Inc. (1)  ·  Centre Hospitalier Universitaire de Saint Etienne (1)  ·  Chulalongkorn University (1)  ·  University of Manitoba (1)

Countries

United States (2)  ·  Canada (1)  ·  France (1)  ·  South Korea (1)  ·  Thailand (1)

Top investigators

Anca D Askanase, MD, MPH (1)  ·  George G Zhanel, PhD, FCCP (1)  ·  Godfrey KM Harding, MD, FRCPC (1)  ·  Lindsay E Nicolle, MD, FRCPC (1)  ·  Pietro Canetta, MD (1)

Results publications

PMID 22995802

NIH funding

2009 (1)